Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by University of Zurich
Sponsor:
Information provided by (Responsible Party):
Oliver Riesterer, University of Zurich
ClinicalTrials.gov Identifier:
NCT01435252
First received: July 26, 2011
Last updated: December 8, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)